SCHEMBL26054976

SCHEMBL26054976

N#Cc1cccc(-c2ccc(-c3nc(-c4ccc(-c5ccccc5C#N)cc4)nc(-c4ccc(-c5cccc(C#N)c5)c(-n5c6ccc(-c7ccccc7)cc6c6cc(-c7ccccc7)ccc65)c4)n3)cc2-n2c3ccc(-c4ccccc4)cc3c3cc(-c4ccccc4)ccc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 8/20 0.41
CYP3A4 P08684 7/20 0.41
ALDH1A1 P00352 5/20 0.41
CYP2D6 P10635 5/20 0.41
CLK4 Q9HAZ1 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
LMNA P02545 4/20 0.41
CYP2C19 P33261 4/20 0.41
TSHR P16473 3/20 0.41
HSD17B10 Q99714 3/20 0.41
CYP2C9 P11712 2/20 0.41
MAPK1 P28482 3/20 0.39
TP53 P04637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 1/20 0.39
ALDH1A3 P47895 1/20 0.38
USP2 O75604 3/20 0.37
NR3C1 P04150 1/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26052026 0.97 CYP1A2 (0.41) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26055268 0.97 CYP1A2 (0.40) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26041180 0.96 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26041183 0.96 CYP1A2 (0.41) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26051961 0.96 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL24924887 0.96 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26041225 0.95 CYP1A2 (0.41) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26051158 0.95 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26052223 0.95 CYP1A2 (0.39) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4
SCHEMBL26055911 0.95 CYP1A2 (0.42) CYP1A2CYP3A4ALDH1A1CYP2D6CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2023-08-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276702-A1 LIGHT-EMITTING TRIAZINE DERIVATIVES FOR OPTOELECTRONIC DEVICES TYR, WIZ, NR2E3 CYP1A2 236/4885CYP3A4 434/4885ALDH1A1 502/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.